Peptide complexes sales will rise through 2036, driven by skin care at 0.1% of the end use application segment in 2026. The market was valued at USD 97.50 billion in 2025 and is expected to be worth USD 329.30 billion by 2036, creating an incremental opportunity of USD 220.39 billion.